We are live on ! Find out more
CCP

Clough Capital Partners Portfolio holdings

AUM $1.23B
1-Year Est. Return 51.32%
This Fund
S&P 500
This Quarter Est. Return
+8.52%
1 Year Est. Return
+51.32%
3 Year Est. Return
+175.14%
5 Year Est. Return
+243.7%
10 Year Est. Return
+1,533.05%
AUM
$882M
AUM Growth
-$95.5M
Cap. Flow
-$129M
Cap. Flow %
-14.59%
Top 10 Hldgs %
34.15%
Holding
168
New
36
Increased
26
Reduced
30
Closed
49

Top Sells

Rank Stock Value
1
ASML icon
ASML
ASML
+$31.8M
2
AAPL icon
Apple
AAPL
+$29.3M
3
SN icon
SharkNinja
SN
+$22.4M
4
BMY icon
Bristol-Myers Squibb
BMY
+$19.5M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$19.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 18.75%
2 Technology 18.7%
3 Industrials 13.32%
4 Communication Services 10.91%
5 Financials 10.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STWD icon
101
Starwood Property Trust
STWD
$5.63B
$542K 0.06%
28,600
HUMA icon
102
Humacyte
HUMA
$153M
$527K 0.06%
104,400
-74,368
-42% -$368K
REGN icon
103
Regeneron Pharmaceuticals
REGN
$79.7B
$509K 0.06%
715
HQL
104
abrdn Life Sciences Investors
HQL
$590M
$505K 0.06%
38,519
HQH
105
abrdn Healthcare Investors
HQH
$1.22B
$501K 0.06%
31,187
VICI icon
106
VICI Properties
VICI
$27.3B
$482K 0.05%
16,500
MDT icon
107
Medtronic
MDT
$120B
$479K 0.05%
6,000
T icon
108
AT&T
T
$183B
$462K 0.05%
20,300
SPOT icon
109
Spotify
SPOT
$115B
$428K 0.05%
956
-184
-16% -$78.8K
UUUU icon
110
Energy Fuels
UUUU
$3.14B
$423K 0.05%
+82,494
New +$510K
OKLO
111
Oklo
OKLO
$6.69B
$412K 0.05%
+19,400
New +$376K
ROIV icon
112
Roivant Sciences
ROIV
$28.5B
$406K 0.05%
34,300
-53,907
-61% -$637K
JNJ icon
113
Johnson & Johnson
JNJ
$644B
$405K 0.05%
2,800
-6,961
-71% -$1.08M
PRU icon
114
Prudential Financial
PRU
$41.2B
$391K 0.04%
3,300
BMEZ icon
115
BlackRock Health Sciences Trust II
BMEZ
$1B
$303K 0.03%
21,036
-2,964
-12% -$45.9K
PL icon
116
Planet Labs
PL
$5.83B
$285K 0.03%
70,500
+8,200
+13% +$25.5K
ITCI
117
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$284K 0.03%
3,400
DFTX
118
Definium Therapeutics
DFTX
$4.95B
$236K 0.03%
+33,900
New +$233K
CDXS icon
119
Codexis
CDXS
$153M
$170K 0.02%
+35,600
New +$147K
A icon
120
Agilent Technologies
A
$42.4B
-71,810
Closed -$10.7M
ABBV icon
121
AbbVie
ABBV
$465B
-30,020
Closed -$5.93M
ACHC icon
122
Acadia Healthcare
ACHC
$2.55B
-4,640
Closed -$294K
AEM icon
123
Agnico Eagle Mines
AEM
$99.7B
-16,451
Closed -$1.33M
AMD icon
124
Advanced Micro Devices
AMD
$823B
-8,025
Closed -$1.32M
AMN icon
125
AMN Healthcare
AMN
$1.32B
-4,800
Closed -$203K

Similar funds

Clough Capital Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Clough Capital Partners held 168 positions worth $882M, down 9.8% from $977M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Clough Capital Partners withdrew a net $129M in Q4 2024, closing 49 positions and reducing 30 holdings. Its most notable exit was ASML, an estimated $31.8M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, down from 22% a quarter earlier, followed by Technology and Industrials.

Against the trend, Clough Capital Partners opened a new position in Philip Morris worth $14.9M.

  • Clough Capital Partners's largest Q4 2024 buy was Philip Morris: 123,480 shares worth $14.9M.
  • Clough Capital Partners added most to Expand Energy Corp in Q4 2024, an estimated $22.7M increase.
  • Clough Capital Partners's biggest Q4 2024 reduction was Apple, cutting an estimated $29.3M.
  • Clough Capital Partners fully exited ASML in Q4 2024, selling an estimated $31.8M.
  • Clough Capital Partners's ten largest holdings make up 34% of its $882M portfolio in Q4 2024.
  • Clough Capital Partners opened 36 new positions and closed 49 in Q4 2024.
  • Clough Capital Partners's portfolio value fell 9.8% quarter-over-quarter to $882M.

Based on Clough Capital Partners's 13F filing for Q4 2024, filed 14 Feb 2025.